FDA Inspection
Barr Laboratories, Inc. (subsidiary of Teva Pharmaceuticals)Barr Laboratories, Inc. (subsidiary of Teva Pharmaceuticals) – FDA Inspection, Jul 17, 2014
Record Details
This FDA Inspection record concerns Barr Laboratories, Inc. (subsidiary of Teva Pharmaceuticals), with an inspection on July 17, 2014, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- July 17, 2014
- Product Type
- Drugs
View Company Profile
ID · 26a1d32d-9afc-4ea1-9b13-54fd5a641d19
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 888727
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
1- 21 CFR 211.165(d)Acceptance/Rejection Levels
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Barr Laboratories, Inc. (subsidiary of Teva Pharmaceuticals)
6| Date | Classification | Office | Project area |
|---|---|---|---|
| January 26, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 6, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 17, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 3, 2012 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 27, 2011 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Barr Laboratories, Inc. (subsidiary of Teva Pharmaceuticals)
- FDA Inspection 1001828 - 2017-01-26
- FDA Inspection 937325 - 2015-08-06
- FDA Inspection 832489 - 2013-05-17
- FDA Inspection 780103 - 2012-05-03
- FDA Inspection 732377 - 2011-06-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.